Clicky

Eli Lilly and Company(LLY)

Description: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Keywords: S&P 500 Pharmaceutical Products Diabetes Antibiotics Health Products Milk Alzheimer's Disease Neuroscience Hypertension Osteoporosis Mental Health Psychiatric Diagnosis Schizophrenia Depression Psychiatry Wholesale Distributor Cattle Animal Health Products Cholesterol Erectile Dysfunction Dysfunction Dog Animal Health Head And Neck Cancer Major Depressive Disorder Pulmonary Arterial Hypertension Bacterial Infections Attention Deficit Hyperactivity Disorder Benign Prostatic Hyperplasia Testosterone Depressive Disorder Endocrinology Growth Hormone Amyloid Bipolar Disorder Mesothelioma Cardiovascular Products Hyperactivity Disorder Hyperplasia Mood Disorders Oncology Products Helio High Cholesterol Psychology Malignant Pleural Mesothelioma Obsessive Compulsive Disorder Vascular Products Growth Hormone Deficiency Percutaneous Percutaneous Coronary Intervention Treatment Resistant Depression Bipolar Depression Brain Imaging Bulimia Nervosa Panic Disorder Respiratory And Other Diseases

Home Page: www.lilly.com

LLY Technical Analysis

Lilly Corporate Center
Indianapolis, IN 46285
United States
Phone: 317 276 2000


Officers

Name Title
Mr. David A. Ricks Chairman, CEO & Pres
Ms. Anat Ashkenazi Sr. VP & CFO
Dr. Daniel M. Skovronsky M.D., Ph.D. Sr. VP, Chief Scientific & Medical Officer and Pres of Lilly Research Labs
Mr. Diogo Rau Sr. VP & Chief Information and Digital Officer
Mr. Jacob S. Van Naarden Sr. VP, CEO of Loxo Oncology & Pres of Lilly Oncology
Mr. Donald A. Zakrowski Chief Accounting Officer & VP of Fin.
Mr. Martin Bott MIBS VP of Fin. & Special Projects
Ms. Anat Hakim J.D. Sr. VP, Gen. Counsel & Sec.
Mr. Alonzo Weems Sr. VP and Chief Ethics & Compliance Officer
Ms. Leigh Ann Pusey Sr. VP of Corp. Affairs & Communications

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 39.0625
Trailing PE: 53.2051
Price-to-Book MRQ: 34.0617
Price-to-Sales TTM: 11.699
IPO Date: 1978-01-13
Fiscal Year End: December
Full Time Employees: 35000
Back to stocks